These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8294146)

  • 1. Divergence between delayed-type hypersensitivity (DTH) to polyoma tumor-associated antigen and antitumor efficacy in polyoma-bearing recipients of therapeutic non-cytolytic, DTH-mediating lymphocytes.
    Ochalek T
    Immunol Lett; 1993 Oct; 38(2):97-102. PubMed ID: 8294146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed hypersensitivity to polyoma and "self" antigens in syngeneic mice.
    Ochałek T; Burzyński A; Cadel Z; Chłap Z; Porwit-Bóbr Z
    Neoplasma; 1987; 34(4):441-51. PubMed ID: 2821418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyoma antigen driven T lymphocytes with antitumor and DTH activity in CBA mice.
    Ochałek T; Cadel Z
    Neoplasma; 1988; 35(3):271-8. PubMed ID: 3261395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of recipients' immune status on effectiveness of adoptive immunotherapy with TAA specific T lymphocytes and interleukin-2 in CBA polyoma mice.
    Ochalek T
    Neoplasma; 1991; 38(2):199-206. PubMed ID: 1645851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro generation of therapeutic noncytolytic T-cells by soluble polyoma TAA and Il-2.
    Ochalek T; von Kleist S
    Anticancer Res; 1993; 13(4):1171-7. PubMed ID: 8394674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection.
    Lukacher AE; Moser JM; Hadley A; Altman JD
    J Immunol; 1999 Sep; 163(6):3369-78. PubMed ID: 10477607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to polyoma virus-induced tumors correlates with CTL recognition of an immunodominant H-2Dk-restricted epitope in the middle T protein.
    Lukacher AE; Wilson CS
    J Immunol; 1998 Feb; 160(4):1724-34. PubMed ID: 9469430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral CD8+ T cell responses in neonatal mice: susceptibility to polyoma virus-induced tumors is associated with lack of cytotoxic function by viral antigen-specific T cells.
    Moser JM; Altman JD; Lukacher AE
    J Exp Med; 2001 Mar; 193(5):595-606. PubMed ID: 11238590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
    Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
    J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed-type hypersensitivity initiation by early-acting cells that are antigen mismatched or MHC incompatible with late-acting, delayed-type hypersensitivity effector T cells.
    Ptak W; Herzog WR; Askenase PW
    J Immunol; 1991 Jan; 146(2):469-75. PubMed ID: 1987274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of a polyoma virus-induced tumor-associated membrane antigen in mouse cells by the macrophage migration inhibition test.
    Ramqvist T; Dalianis T; Reinholdsson G; Klein G; Szigeti R
    Cancer Res; 1986 Oct; 46(10):5045-8. PubMed ID: 3019520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyoma T-antigen-derived synthetic peptides induce polyoma-virus-specific macrophage migration inhibition.
    Reinholdsson G; Ramqvist T; Szigeti R; Dalianis T
    Int J Cancer; 1989 Jun; 43(6):1165-8. PubMed ID: 2543648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell effector function and unresponsiveness in the murine lymphocytic choriomeningitis virus infection. II. Delayed-type hypersensitivity unresponsiveness reflects a defective differentiation from TD precursor to effector cell.
    Thomsen AR; Marker O
    Scand J Immunol; 1986 Aug; 24(2):137-45. PubMed ID: 3489281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ongoing hapten-specific delayed-type hypersensitivity prevents generation of cytolytic T lymphocytes to the same hapten.
    Wong HL; Battisto JR
    Cell Immunol; 1985 Aug; 94(1):205-14. PubMed ID: 3160488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single peptide derived from the sequence common to polyoma small and middle T-antigen induces immunity against polyoma tumors.
    Ramqvist T; Reinholdsson G; Carlquist M; Bergman T; Dalianis T
    Virology; 1989 Sep; 172(1):359-62. PubMed ID: 2475972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
    Peeler JS; Niederkorn JY
    J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones.
    Cher DJ; Mosmann TR
    J Immunol; 1987 Jun; 138(11):3688-94. PubMed ID: 2953788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro induction of delayed-type hypersensitivity to allo-antigens of the mouse.
    Barrington-Leigh J
    J Immunol Methods; 1984 Apr; 69(2):149-63. PubMed ID: 6232322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells). Is in vivo cell transferrable?
    Perez M; Lobo FM; Yamane Y; John L; Berger CL; Edelson RL
    Ann N Y Acad Sci; 1991 Dec; 636():95-112. PubMed ID: 1793234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmentation of antitumor immune response by trinitrophenyl (TNP)-reactive helper T-cells: enhanced induction of tumor-specific Lyt-1+2- T-cell-mediated delayed-type hypersensitivity from spleen cells of tumor-bearing mice by TNP helpers.
    Suda T; Fujiwara H; Mizushima Y; Shearer GM; Hamaoka T
    J Natl Cancer Inst; 1986 Dec; 77(6):1267-72. PubMed ID: 2948049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.